InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $3.23 million. The enterprise value is -$942,137.
Important Dates
The next estimated earnings date is Tuesday, February 11, 2025, before market open.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 718,032 shares outstanding. The number of shares has increased by 222.76% in one year.
| Current Share Class | 718,032 |
| Shares Outstanding | 718,032 |
| Shares Change (YoY) | +222.76% |
| Shares Change (QoQ) | +29.21% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 12.80% |
| Float | 596,802 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.07, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.07 |
| Quick Ratio | 4.12 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.85% and return on invested capital (ROIC) is -46.99%.
| Return on Equity (ROE) | -75.85% |
| Return on Assets (ROA) | -42.47% |
| Return on Capital (ROIC) | -46.99% |
| Revenue Per Employee | $381,577 |
| Profits Per Employee | -$524,353 |
| Employee Count | 13 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.88 |
Taxes
In the past 12 months, INM has paid $7,100 in taxes.
| Income Tax | 7,100 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.57% in the last 52 weeks. The beta is 0.61, so INM's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -29.57% |
| 50-Day Moving Average | 4.69 |
| 200-Day Moving Average | 5.15 |
| Relative Strength Index (RSI) | 57.56 |
| Average Volume (20 Days) | 1,325,148 |
Short Selling Information
The latest short interest is 9,294, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 9,294 |
| Short Previous Month | 13,287 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 1.56% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
In the last 12 months, INM had revenue of $4.96 million and -$6.82 million in losses. Loss per share was -$13.79.
| Revenue | 4.96M |
| Gross Profit | 1.57M |
| Operating Income | -7.26M |
| Pretax Income | -6.07M |
| Net Income | -6.82M |
| EBITDA | -7.04M |
| EBIT | -7.26M |
| Loss Per Share | -$13.79 |
Full Income StatementBalance Sheet
The company has $5.63 million in cash and $1.06 million in debt, giving a net cash position of $4.57 million or $6.36 per share.
| Cash & Cash Equivalents | 5.63M |
| Total Debt | 1.06M |
| Net Cash | 4.57M |
| Net Cash Per Share | $6.36 |
| Equity (Book Value) | 8.40M |
| Book Value Per Share | 12.59 |
| Working Capital | 5.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.64 million and capital expenditures -$9,293, giving a free cash flow of -$6.65 million.
| Operating Cash Flow | -6.64M |
| Capital Expenditures | -9,293 |
| Free Cash Flow | -6.65M |
| FCF Per Share | -$9.26 |
Full Cash Flow StatementMargins
Gross margin is 31.71%, with operating and profit margins of -146.44% and -137.42%.
| Gross Margin | 31.71% |
| Operating Margin | -146.44% |
| Pretax Margin | -137.27% |
| Profit Margin | -137.42% |
| EBITDA Margin | -142.02% |
| EBIT Margin | -146.44% |
| FCF Margin | n/a |